
A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …

The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …

With World Cancer Day on 4 February, Takeda Oncology’s Liviu Niculescu and Stephen J. Noga talk to Pharmafile.com on the …

Research conducted over the course of two decades has found a positive correlation between overall survival in prostate cancer patients …

Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …
Woodley Equipment is exhibiting at Clinical Operations in Oncology Trials Europe, which is taking place on 29th and 30th November Steigenberger …

Cancer Research UK (CRUK) and its commercial arm, Cancer Research Technology (CRT), haven entered into an agreement with TYG Oncology …
There has been positive news coming from researchers at the Huntsman Cancer Institute, at the University of Utah, reporting on …

The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …

IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …

The latest issue of Pharmafocus is now available, and with it comes Advances in Oncology, our supplement featuring all the …

Foundation Medicine hopes to enhance oncologist insight into potential immunotherapy responses with the addition of new clinical markers to its …
Pfizer has sealed the deal to acquire US cancer drug company Medivation for close to $14 billion in a move …

Brisbane-based venture-stage biopharmaceutical company Tioma Therapeutics has announced it has raised $86 million in Series A venture financing for its …